Recent searches
    Trending searches
    ISRG logo Intuitive Surgical +
    +

    Intuitive Surgical Competitors & Alternatives

    Intuitive Surgical competitors and alternatives

    Jump
    Company
    Company
    Ticker
    ISRG
    Headquarter
    Sunnyvale ,CA
    US
    CEO
    Dr. Gary S. Guthart Ph.D.
    Industry
    Medical - Instruments & Supplies
    Stock Price
    Stock Price
    Market Cap
    $189.75 B
    Employees
    Years
    • 2022
    • 2023
    • 2024
    Employees
    • 12.12 K
    • 13.68 K
    • 15.64 K
    Y/Y
    23.76%
    12.84%
    14.35%
    Revenue Per Employee
    Years
    • 2022
    • 2023
    • 2024
    Revenue Per Employee
    • $513.38 K
    • $520.92 K
    • $534.09 K
    Y/Y
    11.95%
    1.47%
    2.53%
    Net Income Per Employee
    Years
    • 2022
    • 2023
    • 2024
    Net Income Per Employee
    • $109.10 K
    • $131.47 K
    • $148.52 K
    Y/Y
    37.32%
    20.5%
    12.97%

    Income Statement

    Revenue
    Years
    • 2022
    • 2023
    • 2024
    Revenue
    • $6.22 B
    • $7.12 B
    • $8.35 B
    Y/Y
    8.97%
    14.49%
    17.24%
    Revenue by Products / Services
    Revenue by Geography
    Research and Development
    Years
    • 2022
    • 2023
    • 2024
    Research and Development
    • $879.00 M
    • $998.80 M
    • $1.15 B
    Y/Y
    31%
    13.63%
    14.67%
    Operating Income
    Years
    • 2022
    • 2023
    • 2024
    Operating Income
    • $1.21 B
    • $1.77 B
    • $2.35 B
    Y/Y
    33.48%
    45.86%
    32.95%
    Tax Rate (%)
    Years
    • 2022
    • 2023
    • 2024
    Tax Rate (%)
    • 16.00%
    • 7.00%
    • 13.00%
    Y/Y
    90.33%
    55.73%
    74%
    Net Income
    Years
    • 2022
    • 2023
    • 2024
    Net Income
    • $1.32 B
    • $1.80 B
    • $2.32 B
    Y/Y
    22.43%
    35.98%
    29.18%

    Assets & Liabilities | Cash Flow

    Total Assets
    Years
    • 2022
    • 2023
    • 2024
    Total Assets
    • $12.97 B
    • $15.44 B
    • $18.74 B
    Y/Y
    4.29%
    19.02%
    21.38%
    Total Liabilities
    Years
    • 2022
    • 2023
    • 2024
    Total Liabilities
    • $1.86 B
    • $2.04 B
    • $2.21 B
    Y/Y
    16.08%
    9.82%
    8.29%
    Capital Expenditures (Capex)
    Years
    • 2022
    • 2023
    • 2024
    Capital Expenditures (Capex)
    • -$532.40 M
    • -$1.06 B
    • -$1.11 B
    Y/Y
    50.61%
    99.89%
    4.42%

    Profitability

    Operating Income Margin (%)
    Years
    • 2022
    • 2023
    • 2024
    Operating Income Margin (%)
    • 19.47%
    • 24.80%
    • 28.12%
    Y/Y
    38.95%
    27.38%
    13.39%
    Net Income Margin (%)
    Years
    • 2022
    • 2023
    • 2024
    Net Income Margin (%)
    • 21.25%
    • 25.24%
    • 27.81%
    Y/Y
    28.81%
    18.78%
    10.18%
    EBITDA
    Years
    • 2022
    • 2023
    • 2024
    EBITDA
    • $1.94 B
    • $2.17 B
    • $2.67 B
    Y/Y
    8.84%
    11.64%
    23.27%
    Free Cash Flow (FCF)
    Years
    • 2022
    • 2023
    • 2024
    Free Cash Flow (FCF)
    • $958.40 M
    • $749.60 M
    • $1.30 B
    Y/Y
    44.79%
    21.79%
    73.93%

    Ratios

    Return on Equity (ROE)
    Years
    • 2022
    • 2023
    • 2024
    Return on Equity (ROE)
    • 11.90%
    • 13.51%
    • 14.13%
    Y/Y
    16.55%
    13.53%
    4.59%
    Return on Assets (ROA)
    Years
    • 2022
    • 2023
    • 2024
    Return on Assets (ROA)
    • 10.19%
    • 11.64%
    • 12.39%
    Y/Y
    19%
    14.23%
    6.44%
    Debt to Equity
    Years
    • 2022
    • 2023
    • 2024
    Debt to Equity
    • 0.84%
    • 0.67%
    • 0.00%
    Y/Y
    15.07%
    20.24%
    100%

    Valuation

    Enterprise Value
    Years
    • 2022
    • 2023
    • 2024
    Enterprise value
    • $92.90 B
    • $115.82 B
    • $183.37 B
    Y/Y
    26.7%
    24.68%
    58.32%
    Enterprise value to Revenue
    Years
    • 2022
    • 2023
    • 2024
    Enterprise value to Revenue
    • 14.93
    • 16.26
    • 21.96
    Y/Y
    32.74%
    8.89%
    35.05%
    Enterprise value to EBITDA
    Years
    • 2022
    • 2023
    • 2024
    Enterprise value to EBITDA
    • 47.81
    • 53.40
    • 68.58
    Y/Y
    19.6%
    11.68%
    28.43%

    Related company

    Submit feedback to Bullfincher